Clearmind Medicine Inc stock is traded at $5.58, with a volume of 13,161. It is down -4.55% in the last 24 hours and down -4.39% over the past month. Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.
Previous Close:
$5.85
Open:
$5.71
24h Volume:
13,161
Relative Volume:
1.92
Market Cap:
$2.83M
Revenue:
-
Net Income/Loss:
-$7.90M
P/E Ratio:
-
EPS:
-$185.93
Net Cash Flow:
-$6.29M
1W Performance:
-10.21%
1M Performance:
-4.39%
6M Performance:
-87.52%
1Y Performance:
-99.76%
1-Day Range:
$5.40$5.71
1-Week Range:
$5.40$6.14
52-Week Range:
$5.25$2,530.88
Clearmind Medicine Inc Stock (CMND) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS